Eli Lilly's second quarter eases Zepbound pricing fears and suggests it's making headway in weight loss race
"Investors were nervous going in and this print would come as a huge relief," said Mohit Bansal, an analyst at Wells Fargo.
"Investors were nervous going in and this print would come as a huge relief," said Mohit Bansal, an analyst at Wells Fargo.
